Informatics

The goal of health informatics systems is to enable smooth transfer of data and cybersecurity across the healthcare enterprise. This includes patient information, images, subspecialty reporting systems, lab results, scheduling, revenue management, hospital inventory, and many other health IT systems. These systems include the electronic medical record (EMR) admission discharge and transfer (ADT) system, hospital information system (HIS), radiology picture archiving and communication systems (PACS), cardiovascular information systems (CVIS), archive solutions including cloud storage and vendor neutral archives (VNA), and other medical informatics systems.

RSS icon
Thumbnail

HFMA 2017: LexisNexis’ Rick Ingraham on using social determinants for ‘proactive patient outreach’

Addressing social determinants of health has been labeled a priority by many studies and healthcare organizations, but that data can also be used by health plans to assess a member’s future risk.

The push toward utilizing IoT

The “internet of things” (IoT) is the bright future of connected technology, yet remains underutilized by healthcare organizations. In a preview presentation by Paul Perry, director of Warren Averett security services, IoT is highlighted for is benefits with connected health.

Thumbnail

HFMA 2017 preview: What the ‘internet of things’ can do for healthcare finance

The “internet of things,” or IoT, is in its infancy everywhere in healthcare, according to Warren Averett security services director Paul Perry. For those on the finance side of hospitals and health systems, he says this connected technology offers great opportunity to those who realize its potential.

6 findings from HIMSS 2017 Precision Medicine Study

The combination of precision medicine and information technology (IT) has the potential to improve patient outcomes. But many healthcare organizations are slow to pursue integration. A recently released report, “2017 Precision Medicine Study," from Healthcare Information and Management Systems Society (HIMSS) outlines how healthcare organizations view the expansion and improvement of IT with precision medicine.

Thumbnail

Health IT groups oppose $22M cut to ONC in Trump’s budget

Reducing funding to the Office of the National Coordinator for Health IT (ONC) from $60 million to $38 million, as the Trump administration has proposed, may hamper advancements in interoperability and the goals of 21st Century Cures Act, according to several leading health IT groups.

Thumbnail

ONC budget cut by $22 million under Trump

Under President Donald Trump's proposed budget, the Office of the National Coordinator for Health Information Technology (ONC) will lose $22 million in funding. The 36 percent reduction cuts the $60 million for ONC to $38 million in 2018.

Thumbnail

HIMSS acquires Health 2.0 conferences

The Health 2.0 conferences, which focused on start-up technologies in healthcare, will now be under the banner of the Healthcare Information and Management Systems Society (HIMSS).

Thumbnail

Health 2.0 conferences acquired by HIMSS

The Healthcare Information and Management Systems Society (HIMSS) has acquired the conference component of Health 2.0, focused on start-up digital technologies in healthcare.

Displaying 105 - 112 of 1011

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.